Sarcopenia, an age-related syndrome characterized by the loss of skeletal muscle mass and function, has become a prominent public health issue. Early screening is crucial for preventing disability and reducing healthcare burden. This article primarily introduces the application status and screening efficacy of commonly used tools such as the sarcopenia screening scale and its modified version, Ishii Score, Mini Sarcopenia Risk Assessment questionnaire, and Finger-ring Test. Furthermore, it delves into future research directions, aiming to systematically summarize the advancements in sarcopenia screening assessment tools and provide a scientific basis for early clinical identification and management.
The spine is one of the most common sites for bone metastases from malignant tumors, and its incidence is increasing year by year. It often leads to severe pain, pathological fractures, nerve compression, and spinal cord dysfunction, seriously affecting the quality of life of patients. The comprehensive treatment of spinal metastases with both traditional Chinese and Western medicine has shown significant efficacy, especially in improving clinical symptoms, promoting postoperative recovery as soon as possible, and enhancing the quality of life. Based on the latest research progress at home and abroad and from the perspective of clinical application, this guideline, grounded in evidence-based medical evidence, has formed 25 recommendations covering treatment objectives, efficacy evaluation, rational selection of traditional Chinese medicine, treatment plans, and postoperative rehabilitation. It provides diagnostic and therapeutic suggestions for orthopedic oncologists, oncologists, radiologists, pain specialists, and other professionals engaged in traditional Chinese medicine, Western medicine, or integrated traditional Chinese and Western medicine, as well as specialized nurses.